APA (7th ed.) Citation

Wang, H., Li, J., Zhu, X., Wang, R., & Wan, Y. A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib. Nature Portfolio.

Chicago Style (17th ed.) Citation

Wang, Huaxiang, Junjun Li, Xiuling Zhu, Ruling Wang, and Yunyan Wan. A Real-world Drug Safety Surveillance Study from the FAERS Database of Hepatocellular Carcinoma Patients Receiving Pembrolizumab Alone and Plus Lenvatinib. Nature Portfolio.

MLA (9th ed.) Citation

Wang, Huaxiang, et al. A Real-world Drug Safety Surveillance Study from the FAERS Database of Hepatocellular Carcinoma Patients Receiving Pembrolizumab Alone and Plus Lenvatinib. Nature Portfolio.